Shareholder Resources

Where is Kymera Therapeutics’ corporate headquarters?

Kymera Therapeutics’ headquarters are located at 200 Arsenal Yards Blvd., Suite 230 Watertown, MA 02472.

When was Kymera Therapeutics founded?

The Company was founded in 2015.

Where is the Company incorporated?

The Company is incorporated in Delaware.

When did Kymera Therapeutics go public?

Kymera Therapeutics completed its IPO on August 20, 2020.

What is Kymera Therapeutics’ fiscal year?

The Company’s fiscal year ends December 31st.

How is Kymera Therapeutics’ stock traded?

The Company’s common stock is listed on the NASDAQ Market under the symbol “KYMR”.

Who is Kymera Therapeutics’ transfer agent?

The transfer agent and registrar for the common stock of Company Therapeutics’ stock is:

Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(800) 962-4284

Whom do I contact with questions about my stock?

For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A..

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?

To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Computershare Trust Company, N.A., 250 Royall Street, Canton, Massachusetts 02021.

To transfer stock or replace a lost stock certificate, contact our transfer agent, Computershare Trust Company, N.A.

Who is Company's auditor?

The auditor for Kymera Therapeutics is Ernst & Young LLP located in Boston, MA.

Who is the Company’s legal counsel?

Legal counsel for Kymera Therapeutics is Goodwin Procter LLP, located in Boston, MA.

Where can I find out more about Kymera Therapeutics?

To find out more about Kymera Therapeutics visit their webpage at www.kymeratx.com.

Where can I get the latest corporate news releases and financial reports?

Kymera Therapeutics’ press release archive can be viewed under the “Events & Presentations” section of the “Investors” page and financial reports are available under the “SEC Filings” section located at our website: www.kymeratx.com.

How can I view documents Kymera Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Kymera Therapeutics’ SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the “Investors” page located at our website www.kymeratx.com.

Who makes up the Kymera Therapeutics Executive Management team and Board of Directors?

For a list of the Management team and Board of Directors, please visit the “About Us” tab of our website.

Whom should I contact regarding investor inquiries?

For investor inquiries, please contact:

Bruce Jacobs
Chief Financial Officer
investors@kymeratx.com
+1 857.285.5300

Christopher F. Brinzey
Westwicke, an ICR Company for Kymera Therapeutics
chris.brinzey@westwicke.com
+ 1 339.970.2843

Email Alerts

Required fields denoted by an asterisk ().

Alert type
Quote
SEC Filing
Event
News
Weekly Summary

Unsubscribe

If you would like to unsubscribe from all Kymera Therapeutics, Inc. email alerts, please click here.

Investor Contact

Paul Cox
VP, Investor Relations and Communications
pcox@kymeratx.com

Christopher F. Brinzey
Westwicke, an ICR Company for Kymera Therapeutics
chris.brinzey@westwicke.com
+ 1 339.970.2843

Media Contact

media@kymeratx.com

Lissette L. Steele
Verge Scientific Communications for Kymera Therapeutics
lsteele@vergescientific.com
+1 202.930.4762

To request information, please fill out and submit the form below.

Investors